NCT00215956 2013-12-23A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal CarcinomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed31 enrolled
NCT00193167 2011-05-03Weekly Topotecan in Patients Treated for Metastatic Colorectal CancerSCRI Development Innovations, LLCPhase 2 Completed40 enrolled
NCT00252889 2009-01-27Doxil Topotecan Doublet Cancer StudyChristiana Care Health ServicesPhase 1 Completed20 enrolled